• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.肺功能差异存在且持续存在于患有囊性纤维化的西班牙裔患者中:一项纵向分析。
Pediatr Pulmonol. 2017 Dec;52(12):1550-1557. doi: 10.1002/ppul.23884. Epub 2017 Oct 30.
2
Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.美国肺功能纵向区域性差异:囊性纤维化患者中西班牙裔和非西班牙裔人群的比较。
Pediatr Pulmonol. 2019 Sep;54(9):1382-1390. doi: 10.1002/ppul.24377. Epub 2019 May 29.
3
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.一大群年轻囊性纤维化患者肺功能下降的危险因素。
Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.
4
The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.西班牙语裔 CF 患者的 CFTR 变异谱:对有效筛查、诊断和个体化医学的影响。
J Genet Couns. 2020 Aug;29(4):607-615. doi: 10.1002/jgc4.1271. Epub 2020 Mar 30.
5
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.囊性纤维化的肺部预后主要受黏液型铜绿假单胞菌感染和免疫状态影响,而受基因型的影响较小。
Infect Immun. 1999 Sep;67(9):4744-50. doi: 10.1128/IAI.67.9.4744-4750.1999.
6
Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.囊性纤维化基金会肺部指南。囊性纤维化跨膜电导调节剂治疗在囊性纤维化患者中的应用。
Ann Am Thorac Soc. 2018 Mar;15(3):271-280. doi: 10.1513/AnnalsATS.201707-539OT.
7
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.使用基线特征对囊性纤维化患者进行最新和预计的生存估计:一项使用英国患者登记数据的纵向研究。
J Cyst Fibros. 2018 Mar;17(2):218-227. doi: 10.1016/j.jcf.2017.11.019. Epub 2018 Jan 6.
8
[Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].[意大利囊性纤维化注册机构(ICFR)。2017 - 2018年报告]
Epidemiol Prev. 2021 May-Jun;45(3 Suppl 1):1-37. doi: 10.19191/EP21.3.S1.050.
9
Treatment of Cystic Fibrosis Patients Homozygous for with Lumacaftor-Ivacaftor (Orkambi) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells.用 Lumacaftor-Ivacaftor(Orkambi)治疗囊性纤维化纯合子患者可恢复循环单个核细胞中缺陷的 CFTR 通道功能。
Int J Mol Sci. 2020 Mar 31;21(7):2398. doi: 10.3390/ijms21072398.
10
CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.囊性纤维化中 CFTR 基因型与最大运动能力:一项横断面研究。
Ann Am Thorac Soc. 2018 Feb;15(2):209-216. doi: 10.1513/AnnalsATS.201707-570OC. Epub 2017 Nov 15.

引用本文的文献

1
Research coordinators' perspectives on recruitment of minoritized people with cystic fibrosis into clinical trials.研究协调员对招募患有囊性纤维化的少数族裔人群参与临床试验的看法。
BMC Pulm Med. 2025 Jul 4;25(1):325. doi: 10.1186/s12890-025-03707-9.
2
Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation.囊性纤维化新生儿筛查:来自美国囊性纤维化基金会的一项基于系统评价的共识指南。
Int J Neonatal Screen. 2025 Apr 2;11(2):24. doi: 10.3390/ijns11020024.
3
Research Coordinators' Perspectives on Recruitment of Minoritized People with Cystic Fibrosis into Clinical Trials.研究协调员对招募少数族裔囊性纤维化患者参与临床试验的看法。
Res Sq. 2024 Nov 13:rs.3.rs-5195002. doi: 10.21203/rs.3.rs-5195002/v1.
4
Evaluating precision medicine tools in cystic fibrosis for racial and ethnic fairness.评估囊性纤维化精准医疗工具在种族和民族公平性方面的情况。
J Clin Transl Sci. 2024 May 7;8(1):e94. doi: 10.1017/cts.2024.532. eCollection 2024.
5
Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.提高加利福尼亚新生儿筛查计划对所有种族和族裔的囊性纤维化检测率。
Pediatr Pulmonol. 2024 Nov;59(11):2901-2909. doi: 10.1002/ppul.27155. Epub 2024 Jun 28.
6
Racial inequities and rare variants: Impact on cystic fibrosis diagnosis and treatment.种族不平等与罕见变异:对囊性纤维化诊断和治疗的影响。
J Clin Transl Endocrinol. 2024 Apr 20;36:100344. doi: 10.1016/j.jcte.2024.100344. eCollection 2024 Jun.
7
Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United States.美国青少年和青年中囊性纤维化肺病快速进展的社会环境表型
Environ Adv. 2023 Dec;14. doi: 10.1016/j.envadv.2023.100449. Epub 2023 Nov 10.
8
Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities.1999 年至 2020 年美国囊性纤维化相关死亡率:时间趋势和差异的观察性分析。
Sci Rep. 2023 Sep 12;13(1):15030. doi: 10.1038/s41598-023-41868-x.
9
Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis.旨在改善肺部健康公平性:囊性纤维化。
Clin Chest Med. 2023 Sep;44(3):555-573. doi: 10.1016/j.ccm.2023.03.011. Epub 2023 May 8.
10
Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis.囊性纤维化患者金黄色葡萄球菌定植的种族差异。
J Cyst Fibros. 2023 Sep;22(5):909-915. doi: 10.1016/j.jcf.2023.07.004. Epub 2023 Jul 16.

本文引用的文献

1
Characterization of Missing Data in Clinical Registry Studies.临床注册研究中缺失数据的特征分析
Ther Innov Regul Sci. 2015 Jan;49(1):146-154. doi: 10.1177/2168479014532259.
2
Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.少数民族在治疗囊性纤维化的药物临床试验中代表性不足。
Ann Am Thorac Soc. 2016 Oct;13(10):1721-1725. doi: 10.1513/AnnalsATS.201603-192BC.
3
Socioeconomic status and health outcomes: cystic fibrosis as a model.社会经济地位与健康结果:以囊性纤维化为例
Expert Rev Respir Med. 2016 Sep;10(9):967-77. doi: 10.1080/17476348.2016.1196140. Epub 2016 Jun 9.
4
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.囊性纤维化基金会患者登记处。一个国家观察性疾病登记处的设计与方法。
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.
5
Assessing Differences in Mortality Rates and Risk Factors Between Hispanic and Non-Hispanic Patients With Cystic Fibrosis in California.评估加利福尼亚州西班牙裔和非西班牙裔囊性纤维化患者的死亡率差异及风险因素
Chest. 2016 Feb;149(2):380-389. doi: 10.1378/chest.14-2189. Epub 2016 Jan 12.
6
Association of improved air quality with lung development in children.空气质量改善与儿童肺发育的关系。
N Engl J Med. 2015 Mar 5;372(10):905-13. doi: 10.1056/NEJMoa1414123.
7
Vital signs: disparities in nonsmokers' exposure to secondhand smoke--United States, 1999-2012.生命体征:1999-2012 年美国不吸烟人群二手烟暴露的差异。
MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):103-8.
8
Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies.儿童早期生活中的空气污染与哮喘风险。GALA II 与 SAGE II 研究。
Am J Respir Crit Care Med. 2013 Aug 1;188(3):309-18. doi: 10.1164/rccm.201302-0264OC.
9
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.用于 3-95 岁年龄范围的肺量测定的多民族参考值:全球肺功能 2012 方程。
Eur Respir J. 2012 Dec;40(6):1324-43. doi: 10.1183/09031936.00080312. Epub 2012 Jun 27.
10
Medication adherence among Latino and non-Latino white children with asthma.拉丁裔和非拉丁裔白种儿童哮喘的药物依从性。
Pediatrics. 2012 Jun;129(6):e1404-10. doi: 10.1542/peds.2011-1391. Epub 2012 May 7.

肺功能差异存在且持续存在于患有囊性纤维化的西班牙裔患者中:一项纵向分析。

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

机构信息

Department of Pediatrics, University of California, San Francisco, California.

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.

出版信息

Pediatr Pulmonol. 2017 Dec;52(12):1550-1557. doi: 10.1002/ppul.23884. Epub 2017 Oct 30.

DOI:10.1002/ppul.23884
PMID:29082671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5693693/
Abstract

BACKGROUND

Hispanic patients with cystic fibrosis (CF) have decreased life expectancy compared to non-Hispanic white patients. Pulmonary function is a main predictor of life expectancy in CF. Ethnic differences in pulmonary function in CF have been understudied. The objective was to compare longitudinal pulmonary function between Hispanic and non-Hispanic white patients with CF.

METHODS

This cohort study of 15 018 6-25 years old patients in the CF Foundation Patient Registry from 2008 to 2013 compared FEV percent predicted and longitudinal change in FEV percent predicted in Hispanic to non-Hispanic white patients. We used linear mixed effects models with patient-specific slopes and intercepts, adjusting for 14 demographic and clinical variables. We did sub-analyses by CFTR class, F508del copies, and PERT use.

RESULTS

Hispanic patients had lower FEV percent predicted (79.9%) compared with non-Hispanic white patients (85.6%); (-5.8%, 95%CI -6.7% to -4.8%, P < 0.001), however, there was no difference in FEV decline over time. Patients on PERT had a larger difference between Hispanic and non-Hispanic white patients in FEV percent predicted than patients not on PERT (-6.0% vs -4.1%, P = 0.02). The ethnic difference in FEV percent predicted was not statistically significant between CFTR classes (Class I-III: -6.1%, Class IV-V: -5.9%, Unclassified: -5.7%, P > 0.05) or between F508del copies (None: -7.6%, Heterozygotes: -5.6%, Homozygotes: -5.3%, P > 0.05).

CONCLUSIONS

Disparities in pulmonary function exist in Hispanic patients with CF early in life and then persist without improving or worsening over time. It is valuable to investigate the factors contributing to pulmonary function in Hispanic patients with CF.

摘要

背景

与非西班牙裔白人患者相比,患有囊性纤维化 (CF) 的西班牙裔患者的预期寿命较短。肺功能是 CF 患者预期寿命的主要预测指标。CF 中肺功能的种族差异研究不足。本研究的目的是比较 CF 中西班牙裔和非西班牙裔白种人患者的纵向肺功能。

方法

本研究对 2008 年至 2013 年期间在 CF 基金会患者注册中心登记的 15018 名 6-25 岁患者进行了队列研究,比较了西班牙裔和非西班牙裔白种人患者的 FEV%预测值和 FEV%预测值的纵向变化。我们使用具有患者特定斜率和截距的线性混合效应模型,调整了 14 个人口统计学和临床变量。我们根据 CFTR 分类、F508del 拷贝数和 PERT 使用情况进行了亚分析。

结果

与非西班牙裔白种人患者(85.6%)相比,西班牙裔患者的 FEV%预测值较低(79.9%);(-5.8%,95%CI -6.7%至-4.8%,P<0.001),但在时间上的 FEV 下降没有差异。使用 PERT 的患者的 FEV%预测值在西班牙裔和非西班牙裔白种人患者之间的差异大于未使用 PERT 的患者(-6.0%比-4.1%,P=0.02)。在 CFTR 分类(I-III 类:-6.1%,IV-V 类:-5.9%,未分类:-5.7%,P>0.05)或 F508del 拷贝数(无:-7.6%,杂合子:-5.6%,纯合子:-5.3%,P>0.05)之间,FEV%预测值的种族差异无统计学意义。

结论

CF 中西班牙裔患者在生命早期就存在肺功能差异,且随着时间的推移,这些差异既没有改善也没有恶化。研究导致 CF 中西班牙裔患者肺功能差异的因素具有重要意义。